Leading Chinese vape brand RELX has started operations at its newly established research laboratory.
The facility, based in China’s tech capital Shenzhen, will conduct research into the effects of vape products through in vivo and in vitro tests, in addition to conducting pre-clinical safety assessments.
The lab is currently conducting research on the impact of RELX products on animal cardiovascular, respiratory and nervous systems, in order to better understand the effects of vape products.
“As the industry leader, we have the responsibility to expand the borders of e-cigarette science and explore the unknown”
Though bodies like Public Health England already state that vaping is up to 95 percent less harmful than smoking cigarettes, the vape industry acknowledges that extensive long-term research is required in order to establish the full harm reduction potential of e-cigarettes.
Meanwhile, misconceptions about vape products and nicotine highlight the need for further research.
RELX co-founder, Yilong Wen, said:
“E-cigarettes are sometimes viewed with suspicion because we have incomplete knowledge.
“The RELX bioscience lab’s mission is to explore the unknown.
“We want to collect evidence through a scientific approach and strive to prove the potential for e-cigarettes to be less harmful, and in doing so, provide users the option to choose an alternative.”
RELX previously established a chemical and physical laboratory in 2018. This laboratory is already certified by the China National Accreditation Service for Conformity Assessment, an internationally recognised body.
The lab has been used to conduct research on the toxicological and pharmacological aspects of RELX products since 2019.
Xingtao Jiang, head of RELX Lab, announced five preliminary findings from RELX’s research so far.
Among these announcements was data on the levels of harmful substances emitted by RELX products, including benzene and four TSNAs (Tobacco-specific N-nitrosoamines).
Emissions of these substances was found to be over 99.1% and 99.8% lower than cigarette smoke respectively.
RELX is currently participating in research projects on various topics in collaboration with six universities, including the Sun Yat-sen University and Shenzhen Institutes of Advanced Technology, the Chinese Academy of Sciences, two hospitals and nine scientific research institutions.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
